Health and Healthcare

Merck : MRK

All Merck Articles

1067 Articles

Chris Lange | Jan 13, 2020 at 9:40 AM EST

Short Sellers Shy Away From Big Pharma

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jan 6, 2020 at 12:45 PM EST

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Here is a review and preview of how the model for Dow Jones industrial average could point to a baseline…

Jon C. Ogg | Jan 2, 2020 at 4:51 PM EST

Is Pfizer Raising Drug Prices Too Much in 2020?

Ahead of election years, the cost and future of health care has become one of the top debates for better…

Chris Lange | Jan 2, 2020 at 10:25 AM EST

The Top Biopharma Events to Watch in 2020

Here, 24/7 Wall St. presents a calendar of a few of the biggest clinical trial and FDA updates to watch…

Chris Lange | Dec 26, 2019 at 8:55 AM EST

Big Pharma Short Sellers Get Selective

The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Dec 23, 2019 at 11:00 AM EST

The Top Biopharma Calendar Events to Watch Going Into 2020

Here, 24/7 Wall St. has included a calendar of a few of the biggest clinical trial and FDA updates to…

Chris Lange | Dec 20, 2019 at 11:45 AM EST

The First Ebola Vaccine Has Been Approved in the US

NewLink Genetics and Merck shares made handy gains on Friday after it was announced that the FDA has granted approval…

Jon C. Ogg | Dec 13, 2019 at 12:25 PM EST

Meet the Preliminary 2020 Dogs of the Dow

One theme that investors love in good times and in bad is dividend investing. One strategy that has been around…

Chris Lange | Dec 11, 2019 at 9:45 AM EST

Big Pharma Short Sellers Grow More Selective

The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Dec 11, 2019 at 7:10 AM EST

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Apple, Microsoft and Intel above all other Dow stocks.

Chris Lange | Dec 9, 2019 at 10:40 AM EST

Why These 3 Biotechs More Than Doubled on Monday

Monday was a breakout day for a few biotech companies. Some made absolutely massive runs, practically doubling and then some.…

Chris Lange | Nov 27, 2019 at 9:00 AM EST

Big Pharma Short Sellers Hike Their Bets

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Nov 18, 2019 at 10:50 AM EST

How Dow 28,000 Can Rapidly Become Dow 30,000 and Even Higher in 2020

Despite the never-ending election cycle, there actually is a clear path for the Dow to hit 30,000 as soon as…

Chris Lange | Nov 12, 2019 at 8:50 AM EST

Big Pharma Scares Off Short Sellers

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Nov 4, 2019 at 11:20 AM EST

As the Dow Hits All-Time High, Over Half of Dow Stocks Keep Disappointing Investors

With markets at all-time highs, it's important to consider the winners and losers. In this case, many stocks in the…

1 … 12 13 14 15 16 … 72

Merck : MRK

All Merck Articles

Short Sellers Shy Away From Big Pharma

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Is Pfizer Raising Drug Prices Too Much in 2020?

The Top Biopharma Events to Watch in 2020

Big Pharma Short Sellers Get Selective

The Top Biopharma Calendar Events to Watch Going Into 2020

The First Ebola Vaccine Has Been Approved in the US

Meet the Preliminary 2020 Dogs of the Dow

Big Pharma Short Sellers Grow More Selective

The 6 Most Shorted Dow Stocks

Why These 3 Biotechs More Than Doubled on Monday

Big Pharma Short Sellers Hike Their Bets

How Dow 28,000 Can Rapidly Become Dow 30,000 and Even Higher in 2020

Big Pharma Scares Off Short Sellers

As the Dow Hits All-Time High, Over Half of Dow Stocks Keep Disappointing Investors

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Merck : MRK

All Merck Articles

Short Sellers Shy Away From Big Pharma

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Is Pfizer Raising Drug Prices Too Much in 2020?

The Top Biopharma Events to Watch in 2020

Big Pharma Short Sellers Get Selective

The Top Biopharma Calendar Events to Watch Going Into 2020

The First Ebola Vaccine Has Been Approved in the US

Meet the Preliminary 2020 Dogs of the Dow

Big Pharma Short Sellers Grow More Selective

The 6 Most Shorted Dow Stocks

Why These 3 Biotechs More Than Doubled on Monday

Big Pharma Short Sellers Hike Their Bets

How Dow 28,000 Can Rapidly Become Dow 30,000 and Even Higher in 2020

Big Pharma Scares Off Short Sellers

As the Dow Hits All-Time High, Over Half of Dow Stocks Keep Disappointing Investors

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do